Cellectis Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Cellectis SA (CLLS)

3.96 +0.06 (+1.54%) USD | NASDAQ | Feb 23, 16:00

3.96 0.00 (0.00%) Pre-Market: 19:59

View Preferred Securities out of Shareholders Equity (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--